Rozwiązania w zakresie zarządzania ruchomością narządową i unieruchomień stosowanych w radioterapii podczas konferencji ESTRO 36 w Wiedniu.

Kaczmarek, Krzysztof

doi:10.21641/los.2019.4.16.143

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The location of the planned treatment volume may change during a treatment session because of the patient’s functional movements, so these shifts must be included in the dimension of the radiation beam [ 52 ]. The larger the radiation beam, the larger the area of healthy tissues surrounding the PTV that receives a high radiation dose [ 53 ].…”

Section: Toxicity Of Breast Cancer Proton Therapymentioning

confidence: 99%

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy

Musielak

Suchorska

Fundowicz

et al. 2021

JPM

View full text Add to dashboard Cite

The toxicity of radiotherapy is a key issue when analyzing the eligibility criteria for patients with breast cancer. In order to obtain better results, proton therapy is proposed because of the more favorable distribution of the dose in the patient’s body compared with photon radiotherapy. Scientific groups have conducted extensive research into the improved efficacy and lower toxicity of proton therapy for breast cancer. Unfortunately, there is no complete insight into the potential reasons and prospects for avoiding undesirable results. Cardiotoxicity is considered challenging; however, researchers have not presented any realistic prospects for preventing them. We compared the clinical evidence collected over the last 20 years, providing the rationale for the consideration of proton therapy as an effective solution to reduce cardiotoxicity. We analyzed the parameters of the dose distribution (mean dose, Dmax, V5, and V20) in organs at risk, such as the heart, blood vessels, and lungs, using the following two irradiation techniques: whole breast irradiation and accelerated partial breast irradiation. Moreover, we presented the possible causes of side effects, taking into account biological and technical issues. Finally, we collected potential improvements in higher quality predictions of toxic cardiac effects, like biomarkers, and model-based approaches to give the full background of this complex issue.

show abstract

Section: Toxicity Of Breast Cancer Proton Therapymentioning

confidence: 99%

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy

Musielak

Suchorska

Fundowicz

et al. 2021

JPM

View full text Add to dashboard Cite

show abstract

Rozwiązania w zakresie zarządzania ruchomością narządową i unieruchomień stosowanych w radioterapii podczas konferencji ESTRO 36 w Wiedniu.

Abstract: Celem niniejszej pracy było zwrócenie uwagi na najnowsze doniesienia technologiczne i trendy w teleradioterapii. Analizę oparto o wybrane raporty oraz problemy badawcze zaprezentowane podczas dorocznego spotkania ESTRO 36 w Wiedniu.

Cited by 1 publication

References 6 publications

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy

Contact Info

Product

Resources

About